Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Brian Bedell
Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).
- Questions
- 94on tracked calls
- Challenge rate
- 1%1 of 94 questions
- Companies
- 17questioned at least once
- Reporting periods
- 7with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 94 of 94 questions from 17 companies
IVZInvesco14 questions · 7 reporting periods · 0 of 14 challenging
Calendar 2026 Q2
Any chance that you can sort of think about when you might turn positive on the equity flows
Show response
Schlossberg framed the outflows as non-recurring institutional mandates and tied recovery to market demand for active equities without committing to a timeline.
can you just talk about the variable the overall variable component of the expenses
Show response
Dukes redirected from the total expense guide to the comp-to-revenue relationship, explaining the Q1 dollar guide was issued because of the sharp AUM move.
Calendar 2026 Q1
Can you talk about the institutional usage versus the retail usage
Show response
Andrew noted institutional ownership growing globally with UCITS version and Asian market listings. Different price points not possible in ETF format but available through separate accounts. QQQ ecosystem totals approximately $550 billion AUM worldwide.
do you think those ratios that relationship is a good run rate to be modeling for the rest of the year?
Show response
Allison confirmed 22-23% third-party/management fee ratio holds going forward. Q1 had $11M reduction from Intelliflo sale in service and distribution fees. Marketing budget remains $60-100M range, fully in run rate, with significant international allocation.
Calendar 2025 Q4
are you seeing actual traction building here this coming year?
Show response
Andrew noted more traction in U.K. and Europe than U.S. for private markets in DC, viewing it as a multi-geography opportunity that LGT partnership will help address given their institutional market reputation.
I just wanted to clarify if that $3.2 billion is the right number to start with, given the isolated impacts that you mentioned
Show response
Allison confirmed $3.2B is correct starting point but with QQQ marketing budget ($60-100M range, near midpoint) as a notable addition not present in 2025. Final 2026 expenses expected somewhat above $3.2B but with higher revenue as well.
Calendar 2025 Q3
On the India sale, is there a segmentation of where that $15 billion is coming out of in the categories?
Show response
Allison confirmed India $15 billion comes out of China JV and India category. QQQ conversion would happen effectively the next day after shareholder meeting if quorum and vote are achieved.
is that moving more into the ETF and index bucket? Or should we think about this over the long term as propelling growth in that ETF and index bucket?
Show response
Andrew expects growth across ETF, SMA, and model portfolio wrappers spanning all investment capabilities. Fixed income ETFs have led growth so far, with equity expected to pick up pace.
Calendar 2025 Q2
the licensing expense to NASDAQ and the administrative to Bank of New York. Do those -- just to clarify, do those both go into the third-party distribution and servicing expense line?
Show response
Allison confirmed all 14 bps (NASDAQ licensing + Bank of New York custody + discretionary marketing) go to third-party distribution expense, leaving clean 4 bps net revenue improvement.
Maybe if you can talk about how you view your position there? What is your strategy?
Show response
Andrew noted regulatory and litigation relief needed first, but Invesco has trust company and collective trust wrapper capabilities plus multi-asset expertise to serve DC plans when market develops.
Calendar 2025 Q1
are you seeing any substantial differences within those local regions, given all of the tariff negotiations
Show response
Andrew noted markets outside US showing better flow resiliency than US in the short run. Diversity across $550B non-US AUM is a key differentiator.
can you talk a little about the economic participation for Invesco Ltd.?
Show response
Andrew confirmed Invesco is distributor and product operator. Revenue sharing terms not disclosed. Too early to estimate growth potential.
Calendar 2024 Q4
how are you thinking about the active ETF line up? Your ETF business has been growing. How do you think about what to transition to have an active tag along it product
Show response
Andrew outlined multiple paths: conversions, cloning, and potential ETF share classes. Cloning sounds elegant but is not always simplest; core focus remains on high-quality investment results.
just your view on the comps revenue ratio that’s within your 1% guide under flat markets
Show response
Allison noted comp-to-revenue at 43% in 2024, targeting return toward 42% range with strong revenue growth. Longer-term target remains 38-42%.
CMECME Group11 questions · 7 reporting periods · 0 of 11 challenging
Calendar 2026 Q2
what would your view be on any potential down the road CFTC approval of equity perps, particularly S&P?
Show response
Terry addressed all parts: swap classification, no need for a separate clearing entity, S&P index exclusivity, and equity-perp systemic risk.
Calendar 2026 Q1
if you could just talk about the April collateral balances that you're seeing so far
Show response
Lynne disclosed April cash balances up to $153B from $149B Q1 average at steady 33bps. Noncash balances also up slightly to $174B from $171B at 10bps. Both trending positively.
What is your view on potentially creating company KPI types of contracts, like financial KPI contracts
Show response
Tim McCourt said there is customer interest but regulatory clarity is needed on security vs commodity classification. No imminent plans or path forward yet, stay tuned.
Calendar 2025 Q4
Can you talk about conversations that you are having with other distribution partners?
Show response
Tim McCourt described robust pipeline with 120-130 retail partners working to connect. Terry clarified CME would list larger political contracts and will participate in sports events as long as CFTC deems them legal swaps.
Calendar 2025 Q3
is this cleared in a club fashion? And in the -- with the FCM that you're cooperating here with FanDuel, just to clarify, would this then be open to all other retail platforms
Show response
Terry confirmed all FCMs can offer event contracts. Lynne clarified DCM and DCO fees are consistent for all participants. FanDuel FCM is one of many; economics with FanDuel involve non-clearing FCM ownership.
Calendar 2025 Q2
Can you just talk about the recent take-up? You said 90,000 customers -- new traders. How you're measuring that?
Show response
Terry noted NCA up 56% is unprecedented. Julie detailed fifth consecutive quarter of double-digit NCA growth, Micro Bitcoin up 94%, Micro Ether up 212%. Tim cited crypto ADV of 190,000 contracts up 130% YoY.
Calendar 2025 Q1
to what extent is this designed for basis trading between treasuries and futures?
Show response
Terry denied basis trade was the impetus for BrokerTec Chicago. Lynne noted Aastra contributed $89M in 2024 earnings, typically $20-22M per quarter. Collateral spread 35bp on cash, 10bp on non-cash.
can you comment on to what extent retail users may use other contracts that's outside of micro, like how good of a proxy is micro for retail?
Show response
Julie and Terry explained retail trades full-size gold and crypto contracts too. Tiering is per-asset-class, intentionally incenting velocity at high-volume periods. Micro gold pricing was increased Feb 1.
Calendar 2024 Q4
can you cite like what portion of your revenue you think is coming from that retail or pro-retail? Or is that too difficult to assess?
Show response
Julie declined to disclose total retail revenue share but reiterated two-thirds of $1 billion NCA revenue over five years comes from retail.
If you can go through the rates coming into 1Q on the cash collateral? And is there -- has there already been any change with the new program coming into this year?
Show response
Lynne provided specific figures: Q4 $75B cash average, Q1 QTD $77B. Non-cash collateral $178B in Q4, $175B QTD. Collateral surcharge doesn't take effect until April.
the simple question is, aren't they all coming in from retail-oriented FCMs, or where is there a mix that you can't tell?
Show response
Terry clarified the blurring is retail vs institutional, not within retail segments. Julie noted non-professional device usage increased almost 40% from Q3 to Q4.
CBOECboe Global Markets7 questions · 6 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
just your level of confidence in getting that approved by the end of the third quarter.
Show response
Craig said the SEC process is going smoothly with a comment period ending the following Wednesday; Rob said KPI pricing will align with other event-contract markets. Direct.
Calendar 2026 Q1
How do you envision this industry playing out over the long term and how Cboe would participate in that?
Show response
Craig and Rob gave a detailed view: early-stage but large opportunity, leading with securities-based XSP binary options and exploring KPI contracts.
Calendar 2025 Q4
the second-quarter launch for the just to clarify, that's for the binary options, I believe
Show response
Rob confirmed Q2 launch is all-or-none style intertwined with SPX spreads, starting with index. Traditional event contracts to follow as market adoption grows. Jill confirmed small revenue contribution in 2026 guide, expects ramp over time. Canada/Australia still in revenue guide since still operating.
Calendar 2025 Q3
Maybe just to focus in on the retail strategy and JJ's game plan for -- maybe just sort of expand more on how you might be doing this differently
Show response
Prashant outlined financial/economic event contracts focus. Rob noted $18B daily SPX premium vs <$50M in prediction markets - opportunity to bring existing liquidity pools. JJ brings 4 decades retail experience.
should we be thinking of the future global footprint for Cboe as largely being U.S. and European centric?
Show response
Craig confirmed US/Europe focus for operations. Chris added FX remains global, European equities in 5th straight quarter as top grower. Jill clarified 3% revenue/8-10% expense figures are aggregate across all actions including Japan.
Calendar 2025 Q2
your perspective on how the securities exchange industry has evolved and how you think it might evolve in the future?
Show response
Craig said retail is structural not cyclical. Exchange companies have become diverse portfolios. Looking at digitization, tokenization, prediction markets as relevant to the evolving landscape. Wants to ensure Cboe competes.
Calendar 2025 Q1
just trying to get a sense of the conservatism in that considering you know, the potential for organically growing your products
Show response
Dave acknowledged good ACV growth (47% up, off 18% in 2024) but noted uncertainty in macro setup. Constructive outlook with guides to be updated quarterly.
HOODRobinhood Markets, Inc.7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
in terms of migrating more of the event contracts at Hood now to Roth era such as NFL
Show response
Vlad deferred on CBOE-style KPI contracts given the securities regime; Shiv confirmed a good portion of event flow should migrate to Rothera.
Calendar 2026 Q1
how are you seeing the customer mix evolve from those new deposits
Show response
Vlad emphasized the Gold attach rate jump to 40% driving multiproduct adoption. Banking and credit card as daily-use products create engagement beyond trading cycles.
Calendar 2025 Q4
what is your appetite for launching contracts in fundamentals, so things like on KPIs and other earnings metrics
Show response
Vlad confirmed strong interest but noted regulatory ambiguity, some financial KPI contracts could fall under securities-based swaps and SEC jurisdiction. Currently have Tesla deliveries contracts. Shiv confirmed Rothera targeting mid-2026 launch.
Calendar 2025 Q3
how the customer behavior has been forming just in the last 2 months. We've seen a big increase in volume, obviously, in September with the NFL and college games added
Show response
Vlad confirmed over 1,000 live event contracts with new entertainment and culture categories. Adoption strong from existing traders plus new customers joining specifically for prediction markets. Jason added relatively small portion of customers participating so far, suggesting significant room for growth with UI and discoverability improvements.
Calendar 2025 Q2
I think you mentioned, Vlad, there are at least a couple of businesses now in the $50 million range. If you could just elaborate
Show response
Jason listed TradePMR, Bitstamp, prediction markets, index options, Gold card, and Legend as businesses scaling toward $100M revenue. Did not provide specific timeline for staking or stock tokens.
Calendar 2025 Q1
can you talk about what you're seeing from active traders coming into the complex and the usage on Legend?
Show response
Jason confirmed strong sequential growth in Legend volumes with vast majority incremental. Did not update $50M ARR figure. Vlad outlined futures on Legend and live streaming improvements as roadmap.
Calendar 2024 Q4
How should we think about how that is pacing in terms of a growth rate?
Show response
Jason confirmed strong week-over-week growth rates for all three products and expressed optimism about market share gains. Vlad noted products are compounding on each other.
NDAQNasdaq, Inc.7 questions · 7 reporting periods · 0 of 7 challenging
Calendar 2026 Q2
Just your views on the future of Reg NMS just given the -- with the SEC proposals out
Show response
Adena gave a detailed view on Reg NMS/order protection rule reform, seeing room to innovate on market models while preserving resiliency and the NBBO.
Calendar 2026 Q1
can you also talk about the potential impact across your fintech platform as the clients increasingly need to respond to always on
Show response
Friedman outlined four demand vectors from always-on transition: surveillance for international hours trading, Eclipse trading platform for markets extending hours, Calypso collateral management across all markets and clearing houses, and trade management services colocation for 23/5 support.
Calendar 2025 Q4
should we think of potentially an acceleration of RegTech and cap markets revenue growth higher towards the higher end of those ranges or at least acceleration on a full-year basis in '26 versus '25
Show response
Friedman declined specific 2026 outlook but emphasized strong pipeline engagement across all FinTech subdivisions globally. Cautioned Q4 is cyclically largest sales quarter. Innovation at scale continuing as core strategy.
Calendar 2025 Q3
Do you see the emergence of your AI solutions helping to advance that faster? And then if you can just remind us where you are currently on that revenue synergy target
Show response
Friedman confirmed 30 cross-sells since Adenza close with 15% pipeline persistence. AI capabilities including GenAI upsells acting as catalyst for cross-sell and upsell activity, giving increased confidence in $100M run rate target by end of 2027.
Calendar 2025 Q2
does this imply you'd be higher within that range given the strength in the second quarter
Show response
Friedman maintained general consistency on outlook despite Q2 strength, and confirmed crypto institutionalization was not part of original Adenza thesis but represents upside opportunity.
Calendar 2025 Q1
to what extent your global business and the global nature of Acxiom is maybe potentially offsetting some of those headwinds
Show response
Friedman highlighted global diversification across 100+ regulators, Basel III timing shifts, and crypto as a growth driver for surveillance, Calypso, and Verafin if regulated.
Calendar 2024 Q4
They look very strong in the fourth quarter versus the 2024 trend -- quarterly trends and also versus the third quarter
Show response
Friedman confirmed Q4 is seasonal high for sales but noted strong trends carrying into 2025 with excellent client engagement.
BXBlackstone Inc.6 questions · 6 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
even after a potentially really strong year this year to actually continue to grow into 2027
Show response
Gray expressed confidence in continued fundraising growth across institutional, insurance, and wealth channels, aided by an eventually more settled rate backdrop.
Calendar 2026 Q1
what you're hearing from financial advisers, and sort of the composition of the clients that are asking for redemption requests
Show response
Gray noted redemptions driven by fewer large investors averaging double the typical investor size, same pattern as BREIT. Expects competitive shakeout to benefit BX market share as weaker competitors diminish.
Calendar 2025 Q4
looking at base management fee growth of probably 11%-ish or similar in '26 to '25, again, just because the ramp is happening in the back half. But as we get into '27, does that portend an inflecti...
Show response
Chae confirmed strong multi-year outlook with 2027 benefiting from full-year drawdown fund contributions, infrastructure three-year incentive fee, and operating leverage. Declined to specify FRE margin ceiling.
Calendar 2025 Q3
Are you seeing banks become more competitive in the direct lending business, how is that impacting spreads?
Show response
Gray said bank competition is a constant but rising deal volumes help supply-demand balance. Insurance momentum is exceptional with open architecture model as a key differentiator.
Calendar 2025 Q1
do you see any friction in the system as a result of some of the tariff back and forth and maybe if you can comment on that situation in both Europe and Asia
Show response
Gray said no material pullback from global clients or private wealth, and BX has benefited from currency strengthening in the U.K., Europe, and yen.
Calendar 2024 Q4
just wondering what your outlook for the FRE margin might be in '25, even just not even considering fee-related performance revenue
Show response
Chae outlined 10% base management fee growth as a starting point, with OpEx growth at 11%, and noted FRPR carries higher incremental margins.
Show 11 more companies
SCHWCharles Schwab Corporation6 questions · 6 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
Can you just talk a little bit about the timing of your upcoming launch with Cboe, re the binary index options?
Show response
Working with Cboe on binary options but no timeline; interested in KPI and information markets, but rejects sports-gambling prediction markets.
Calendar 2026 Q1
Any color around -- first on the NNA, we've seen the adviser side grow faster than the retail side
Show response
Wurster highlighted Investor Services reached an all-time monthly NNA high in March, exceeding Advisor Services. Verdeschi attributed cash build to equity market decline, long-short strategies, and strong NNA rather than primarily tax-related.
Calendar 2025 Q4
if the contracts were to develop in more broadly in fundamental investing and other economic types of contracts, is that something you would be interested in launching on the platform?
Show response
Rick distinguished financial prediction markets (open to if demand develops) from sports gambling (explicitly rejected). Noted 95% of current prediction market volume is sports gambling. Active traders prioritizing mobile app, research, and futures/options over prediction markets.
Calendar 2025 Q3
Any color on the revenue and expense components of that? Obviously, things are trending much better than initially expected
Show response
Mike confirmed revenue and expense both higher than July scenario, with expenses at or slightly above 5.25%. NIM expected into the 2.80s for Q4. Hedging cut ~1/3 of rate sensitivity.
Calendar 2025 Q2
if you can talk about your confidence in being within that 5% to 7% organic growth band for the full -- on an annualized basis
Show response
Rick expressed high confidence in second half NNA, noting June acceleration post-tax outflows. Highlighted two growth prongs: NNA growth and deepening client relationships.
Calendar 2024 Q4
do you think you can get back to that 5% level at some point this year
Show response
Rick confirmed expectation of progress toward 5-7% range in 2025, up from 4.3% in 2024, while Mike noted account growth as key driver of deposit formation.
BLKBlackRock5 questions · 5 reporting periods · 0 of 5 challenging
Calendar 2026 Q2
Can you talk a little bit about how you see the democratization of retail investing in Europe
Show response
Larry described accelerating European ETF adoption, $1.5 trillion AUM, a nationalization trend toward local investing, and dollar-allocation dynamics tied to Fed policy.
Calendar 2026 Q1
As you grow organic base fee growth faster, do you see a better ability to scale that over time?
Show response
Martin noted GIP and HPS were north of 50% FRE margins at acquisition, sees recurring FRE margin trending toward best-in-class private markets names. Fee rate up 0.2bp sequentially driven by international equities and structural growers.
Calendar 2025 Q3
do you envision having this be BlackRock, Inc. centric digital wallets or rather participate in the broader intermediated ecosystem
Show response
Martin described partnership model with leading exchanges to build model portfolios mixing crypto, tokenized products, and traditional assets in digital wallets. Tokenization can solve settlement system fragmentation, eliminating PDF sub-docs for private markets.
Calendar 2025 Q2
you're continuing to see strong organic growth in the fixed income, iShares franchise
Show response
Management cited European ETFs at $1 trillion with 40% market share. Europe 5-6 years behind U.S. in ETF adoption, just beginning same growth trajectory. 38 iShares products had over $1 billion of net inflows in the quarter.
Calendar 2024 Q4
talk a little bit about your confidence, clearly, you have a lot of ways to go into the retail on the Alts side
Show response
Martin outlined Partners Group model solution, European LTIF 2.0 evergreen funds, HPS bringing $20B+ wealth assets including HLEND BDC. Identified target date funds and managed models as two best execution channels for retail alts.
BNYBNY Mellon5 questions · 3 reporting periods · 0 of 5 challenging
Calendar 2025 Q2
Focusing on the cost reduction element as we've, you know, we have another fifty percent to migrate
Show response
CFO reframed as 'running better' not cost-cutting, noting wave one businesses show notably higher maturity. Platform model creates flywheel of momentum with benefits expected for multiple years.
Calendar 2025 Q1
are the efficiencies and the cross-sell and if I can throw AI in there as well, are these contributions exceeding your expectations
Show response
CEO framed benefits as a multi-year arc: short-term Catalyst savings still flowing, platform model payoffs in 2026-27, and AI benefits building through the end of the decade. Gross savings and investment both meaningfully higher than prior years.
Calendar 2024 Q4
to start with net interest revenue and appreciate all the commentary you made, Dermot, on the factors on that
Show response
CFO guided for roughly flat balances with NIBs expected to moderate from Q4 levels, with continued proactive asset-side management driving the mid-single-digit NII guide.
I think, Dermot, you mentioned -- and maybe I missed this, you said you had a revenue guide
Show response
CFO guided $60-70M incremental Wove revenue for 2025 on top of 2024 base, with 36 clients live and 41 signed contracts demonstrating strong adoption momentum.
does this assume generally flat markets? I guess that would be in line with your uncertainty commentary
Show response
CFO confirmed neutral market growth assumption and quantified sensitivity at approximately $70M in fees per 5% market move, providing clear framework for modeling.
APOApollo Global Management4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2026 Q2
Can you talk about what you see as the sort of realistic intermediate to longer-term addressable market
Show response
Zelter framed ICE JV trading as early-stage, citing fivefold volume growth and expecting a more meaningful revenue contribution in 2 to 3 years.
Calendar 2025 Q4
what kind of progress you're seeing in the DOL and for planned sponsors in terms of their appetite to adopt alternative products
Show response
Rowan confirmed open architecture strategy with more partnerships expected. 401(k) will be north of $1B this year but big volumes await rulemaking/guidance. Moving high-grade credit to daily NAV is the unlock for traditional managers.
Calendar 2025 Q3
are you seeing any near-term traction from plan sponsors in thinking about adding privates to their portfolios?
Show response
Rowan said guaranteed lifetime income is the holy grail for deaccumulation. 401(k) crossed a couple of billion in managed account platforms. Administration guidance helpful but awaiting formal ruling for massive take-up.
Calendar 2025 Q2
some perspective on sort of the road map of new initiatives within this since Investor Day and maybe focusing on the trading of private credit
Show response
Zelter discussed the flywheel connecting ACS to trading and described how transparency and liquidity expand the pie. Noted broader impact from trading ecosystem expected in 12 to 24 months. SRE rate cut sensitivity deferred to follow-up.
BENFranklin Resources4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2026 Q1
could you talk about what market you are targeting and the different product types
Show response
Jenny: two near-term opportunities, Benji stablecoin-to-yield conversion, and tokenized ETFs on exchanges (8 on Kraken, 5 on Ondo). Top 5 exchanges have ~1 billion wallets as new client base. 250 Digital bringing institutional crypto venture capability (launching fall). Traditional distributors lack wallets, limiting near-term adoption. Hockey-stick potential depends on exchange adoption speed.
Calendar 2025 Q3
One is just on your views on credit quality in direct lending
Show response
Jenny stated economy still very strong, consumer strong. Slight uptick in subprime just returning to normal levels. Fixed income market priced for perfection. Very tiny BSP exposure to one of the high-profile problem credits (appeared to be fraud, not systemic). Apera brings lower middle market direct lending in Europe, not a crowded space. Ability to pivot between credit types is important.
Calendar 2025 Q2
What is your, I guess, desire or your plans to potentially integrate private and public products?
Show response
Jenny detailed $428B retirement assets, $120B in DC. Target date fund ~$19B (from Putnam). Partnership with Apollo on DC private markets. Empower doing adviser-managed accounts with Morningstar where Franklin participates. DC space highly litigious, awaiting DOL safe harbor. Target dates with private markets models launching first half 2026. $2B in sales pipeline for DC space.
Calendar 2025 Q1
How do you how are you positioned from that dynamic within these regions?
Show response
Adam noted $470B sourced from outside US. Shift to non-dollar assets and growth-to-value rotation both play to Franklin strengths. International and global equity products well positioned for diversification trend.
KKRKKR4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2025 Q4
Just wanted to get your confidence on that $7 between those components and then a couple of cleanups just on catch-up fees in the fourth quarter and timing for the Arctos close
Show response
Rob confirmed Arctos close expected Q2 2026. Catch-up fees $26M. Insurance pivot to alternatives and cash accounting makes TOE metric less relevant than originally discussed. Insurance $1B operating earnings +/- for 2026, plus $350M accrued income not in P&L. Strategic Holdings expects to beat $350M guide.
Calendar 2025 Q3
as you think about expanding the overall ROE past the 20% on the fee side, can you talk about that -- the expansion within the Capital Markets business
Show response
Rob confirmed Page 20 figures are all net of 17.5% comp. GA-related Capital Markets opportunity remains hundreds of millions annually, expected to materialize over next couple of years.
Calendar 2025 Q2
is there anything else unusual in terms of like catch-up fees or anything else?
Show response
Rob said Americas XIV contributed ~$30M in Q2, some Real Assets catch-up fees. Q3 capital markets expected plus or minus in line with Q2. Scott noted 70-80% of pretax income is durable and repeatable.
Calendar 2025 Q1
do you see any kind of ceiling in that, it was basically the view of investing more
Show response
Rob reiterated mid-60% FRE margin sustainable with no cap, citing revenue growth outpacing headcount and operating complexity. Distribution costs described as highest-ROI expense at KKR.
NTRSNorthern Trust4 questions · 2 reporting periods · 0 of 4 challenging
Calendar 2025 Q2
Can you comment about like how that's enhancing the ability for client delivery and relationship management
Show response
O'Grady detailed three categories: process digitization (trust documents), partner tools (AI-powered knowledge access for advisers), and direct client capabilities. Also discussed segment refinement for the $10M-$100M tier to drive stronger organic growth.
can you strip out the allocation between those 2 segments? And I guess what I'm getting at is, excluding GFO, what do you really see as the current penetration
Show response
O'Grady noted GFO alternatives penetration is actually lower than core wealth since GFO clients go direct to large managers, but 50 South research brings differentiated access. Vehicles evolving from standard funds to interval and evergreen structures for democratization.
Calendar 2024 Q4
to the extent NII oscillates around that target range, let's say, if it's lower, are you still keeping a target
Show response
O'Grady emphasized expense control as the controllable lever regardless of NII or market-driven revenue variability.
How are you envisioning that over the next year, one to two years in longer-term product
Show response
O'Grady described closer alignment between NTAM and wealth management, segmenting solutions for GFO vs core wealth vs ultra-high net-worth.
STTState Street Corporation4 questions · 2 reporting periods · 0 of 4 challenging
Calendar 2025 Q2
The housekeeping is just the -- your assumptions on market returns for the second half that underpin the 5% to 7% guide
Show response
Mark noted original assumption was 5% point-to-point / 8% average market levels for the year, currently tracking better. Acknowledged considerable volatility makes projections uncertain.
On the concept of tokenization of equities and ETPs and other assets, how are you thinking about that longer term?
Show response
Ron sees tokenization accelerating as regulatory frameworks emerge but slower than optimists expect. Opportunities broad: tokenized deposits, money market funds for collateral, real assets. Key regulatory question is impact on core deposits and banks as monetary policy transmitters. STT positioning as servicer first, bank participant second.
Calendar 2024 Q4
what is the interest of doing any sort of more aggressive deposit raising? How do you think about that?
Show response
Mark confirmed deposit expansion is embedded in outlook and the firm has built the muscle for client deposit engagement over recent years.
what's your view of 401(k) plans, potentially adopting alternative products? Would you be positioned to offer those?
Show response
Ron highlighted STT's DC innovation including annuities in target date funds, but noted plaintiff's bar challenges to alternative adoption. Would need DOL safe harbor rule.
ICEIntercontinental Exchange3 questions · 3 reporting periods · 0 of 3 challenging
Calendar 2026 Q2
are you looking at consensus expectations for revenue and expenses in your deal accretion analysis?
Show response
Gardiner confirmed consensus EPS as the accretion base and said revenue synergies are hard to quantify. The management-retention and rearchitecting part of the question went unaddressed.
Calendar 2026 Q1
FIDS overall recurring revenue going up 5%, 6%, 7%, 8% and now 9% on a year-over-year basis the last 5 quarters
Show response
Management expressed incremental confidence in higher-end mid-single-digit FIDS targets, noting data center hall timing may moderate H2 growth.
Calendar 2025 Q3
was that the whole segment? Or was that just for recurring? I know you did mention the seasonality in transaction fees
Show response
Warren clarified flat Q4 guidance was recurring only; transactions have seasonal Q4 softness. MBA forecasting high single-digit loan growth for 2026. Ben said PennyMac departure was unsurprising given prior dispute.
ARESAres Management Corporation2 questions · 2 reporting periods · 1 of 2 challenging
Calendar 2025 Q3
Do you think there's anything structurally going on in the industry aside from a credit cycle that is creating these fraud events
Show response
Mike characterized fraud events as possibly coincidental or driven by new entrants taking unfamiliar risks. Noted Ares categorically avoids trade finance. 65% and growing of private credit assets in hands of large incumbents. Data from banks, card companies shows no systemic deterioration.
Calendar 2025 Q2
in terms of time line, I think typically, it takes -- you kind of say it's like 1 to 2 years
Show response
Mike noted historical dry powder vs deployment has been roughly one-to-one. Current $105B not yet paying fees vs LTM deployment in similar range. Deployment pace suggests closer to 12-month conversion.
TROWT. Rowe Price1 question · 1 reporting period · 0 of 1 challenging
Calendar 2025 Q2
some updated thoughts, Rob, on this? I know you spoke about this on the first quarter call but we've had some obviously additional information since then
Show response
Rob gave extensive answer on the investment case for privates in DC, noting continued plan sponsor caution on fees and fiduciary risk. Waiting on DOL/SEC guidance.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| IVZ Invesco | 14 | 0%none of 14 questions |
| CME CME Group | 11 | 0%none of 11 questions |
| CBOE Cboe Global Markets | 7 | 0%none of 7 questions |
| HOOD Robinhood Markets, Inc. | 7 | 0%none of 7 questions |
| NDAQ Nasdaq, Inc. | 7 | 0%none of 7 questions |
| BX Blackstone Inc. | 6 | 0%none of 6 questions |
| SCHW Charles Schwab Corporation | 6 | 0%none of 6 questions |
| BLK BlackRock | 5 | 0%none of 5 questions |
| BNY BNY Mellon | 5 | 0%none of 5 questions |
| APO Apollo Global Management | 4 | 0%none of 4 questions |
- IVZInvesco · 14 questions0%none of 14 questions
- CMECME Group · 11 questions0%none of 11 questions
- CBOECboe Global Markets · 7 questions0%none of 7 questions
- HOODRobinhood Markets, Inc. · 7 questions0%none of 7 questions
- NDAQNasdaq, Inc. · 7 questions0%none of 7 questions
- BXBlackstone Inc. · 6 questions0%none of 6 questions
- SCHWCharles Schwab Corporation · 6 questions0%none of 6 questions
- BLKBlackRock · 5 questions0%none of 5 questions
- BNYBNY Mellon · 5 questions0%none of 5 questions
- APOApollo Global Management · 4 questions0%none of 4 questions
Show all 17 companies
| Company | Questions | Challenge rate |
|---|---|---|
| BEN Franklin Resources | 4 | 0%none of 4 questions |
| KKR KKR | 4 | 0%none of 4 questions |
| NTRS Northern Trust | 4 | 0%none of 4 questions |
| STT State Street Corporation | 4 | 0%none of 4 questions |
| ICE Intercontinental Exchange | 3 | 0%none of 3 questions |
| ARES Ares Management Corporation | 2 | —Rate withheld: fewer than 3 questions |
| TROW T. Rowe Price | 1 | —Rate withheld: fewer than 3 questions |
- BENFranklin Resources · 4 questions0%none of 4 questions
- KKRKKR · 4 questions0%none of 4 questions
- NTRSNorthern Trust · 4 questions0%none of 4 questions
- STTState Street Corporation · 4 questions0%none of 4 questions
- ICEIntercontinental Exchange · 3 questions0%none of 3 questions
- ARESAres Management Corporation · 2 questions—rate withheld: under 3 questions
- TROWT. Rowe Price · 1 question—rate withheld: under 3 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 17 | 0%none of 17 questions | 10 |
| 2025 Q1 | 11 | 0%none of 11 questions | 9 |
| 2025 Q2 | 18 | 0%none of 18 questions | 15 |
| 2025 Q3 | 15 | 7%1 of 15 questions | 13 |
| 2025 Q4 | 10 | 0%none of 10 questions | 9 |
| 2026 Q1 | 12 | 0%none of 12 questions | 10 |
| 2026 Q2 | 11 | 0%none of 11 questions | 10 |
- 2024 Q417 questions · challenge rate 0% (none of 17 questions) · 10 companies
- 2025 Q111 questions · challenge rate 0% (none of 11 questions) · 9 companies
- 2025 Q218 questions · challenge rate 0% (none of 18 questions) · 15 companies
- 2025 Q315 questions · challenge rate 7% (1 of 15 questions) · 13 companies
- 2025 Q410 questions · challenge rate 0% (none of 10 questions) · 9 companies
- 2026 Q112 questions · challenge rate 0% (none of 12 questions) · 10 companies
- 2026 Q211 questions · challenge rate 0% (none of 11 questions) · 10 companies
Topics
Topics tagged on this analyst’s questions.
- Revenue Growth30
- Product Launch25
- Demand21
- Regulation Policy17
- Innovation & R&D16
- Margin15
- Competitive Dynamics12
- Subscriber Growth10
- Geographic Expansion9
- Guidance Reliability7
Show all 18 topics
- Pricing6
- Credit5
- Capital Allocation4
- M&A4
- Cost Pressure3
- Macroeconomic3
- Cloud & AI2
- Trade Tariffs2